The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy

Epigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methyl...

Full description

Bibliographic Details
Main Authors: Yuanling Zhang, Junhao Chen, Hang Liu, Rui Mi, Rui Huang, Xian Li, Fei Fan, Xueqing Xie, Jie Ding
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1099892/full
_version_ 1797956007790379008
author Yuanling Zhang
Yuanling Zhang
Junhao Chen
Hang Liu
Rui Mi
Rui Huang
Xian Li
Fei Fan
Xueqing Xie
Jie Ding
author_facet Yuanling Zhang
Yuanling Zhang
Junhao Chen
Hang Liu
Rui Mi
Rui Huang
Xian Li
Fei Fan
Xueqing Xie
Jie Ding
author_sort Yuanling Zhang
collection DOAJ
description Epigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methylase and histone demethylase to stabilize transcription levels in the promoter area, is one of the most common types of epigenetic alteration, which gained increasing interest. It can modify gene transcription through chromatin structure and affect cell fate, at the transcriptome or protein level. According to recent research, histone methylation modification can regulate tumor and immune cells affecting anti-tumor immune response. Consequently, it is critical to have a thorough grasp of the role of methylation function in cancer treatment. In this review, we discussed recent data on the mechanisms of histone methylation on factors associated with immune resistance of tumor cells and regulation of immune cell function.
first_indexed 2024-04-10T23:42:04Z
format Article
id doaj.art-f26aae87050041428e1a4bf68a698825
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-10T23:42:04Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-f26aae87050041428e1a4bf68a6988252023-01-11T06:46:20ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-01-011310.3389/fimmu.2022.10998921099892The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapyYuanling Zhang0Yuanling Zhang1Junhao Chen2Hang Liu3Rui Mi4Rui Huang5Xian Li6Fei Fan7Xueqing Xie8Jie Ding9School of Medicine, Guizhou University, Guiyang, ChinaDepartment of Gastrointestinal Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaGraduate School of Zunyi Medical University, Zunyi, ChinaDepartment of Medical Cosmetology, Guizhou Provincial People’s Hospital, Guiyang, ChinaDepartment of General Surgery, Zhijin County People’s Hospital, Bijie, ChinaDepartment of Gastrointestinal Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaOrthopedics Department, Dongguan Songshan Lake Tungwah Hospital, DongGuan, ChinaDepartment of Thyroid and Breast Surgery, Affiliated Hospital of Panzhihua University, Panzhihua, ChinaSchool of Medicine, Guizhou University, Guiyang, ChinaDepartment of Gastrointestinal Surgery, Guizhou Provincial People’s Hospital, Guiyang, ChinaEpigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methylase and histone demethylase to stabilize transcription levels in the promoter area, is one of the most common types of epigenetic alteration, which gained increasing interest. It can modify gene transcription through chromatin structure and affect cell fate, at the transcriptome or protein level. According to recent research, histone methylation modification can regulate tumor and immune cells affecting anti-tumor immune response. Consequently, it is critical to have a thorough grasp of the role of methylation function in cancer treatment. In this review, we discussed recent data on the mechanisms of histone methylation on factors associated with immune resistance of tumor cells and regulation of immune cell function.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1099892/fullhistone methylationepigenetic modificationtumorantitumor immunityimmunotherapy
spellingShingle Yuanling Zhang
Yuanling Zhang
Junhao Chen
Hang Liu
Rui Mi
Rui Huang
Xian Li
Fei Fan
Xueqing Xie
Jie Ding
The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
Frontiers in Immunology
histone methylation
epigenetic modification
tumor
antitumor immunity
immunotherapy
title The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
title_full The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
title_fullStr The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
title_full_unstemmed The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
title_short The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy
title_sort role of histone methylase and demethylase in antitumor immunity a new direction for immunotherapy
topic histone methylation
epigenetic modification
tumor
antitumor immunity
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1099892/full
work_keys_str_mv AT yuanlingzhang theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT yuanlingzhang theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT junhaochen theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT hangliu theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT ruimi theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT ruihuang theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT xianli theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT feifan theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT xueqingxie theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT jieding theroleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT yuanlingzhang roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT yuanlingzhang roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT junhaochen roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT hangliu roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT ruimi roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT ruihuang roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT xianli roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT feifan roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT xueqingxie roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy
AT jieding roleofhistonemethylaseanddemethylaseinantitumorimmunityanewdirectionforimmunotherapy